Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Denosumab biosimilar by Luye Pharma Group for Osteoporosis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Luye Pharma Group and currently in Phase III for Osteoporosis. According to GlobalData,...
Data Insights
Denosumab biosimilar by Luye Pharma Group for Post Menopausal Osteoporosis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Luye Pharma Group and currently in Phase III for Post Menopausal Osteoporosis. According...